Contributed by Marie Therese Manipadam, M.B.B.S., M.D.
Tumor with diffuse involvement
Large lymphoid tumor cells
Immunoblast-like
tumor cells and
few plasmablasts
Interfollicular expansion by tumor cells
Intrasinusoidal growth of tumor
Cytoplasmic granular ALK positivity
MUM1 positivity
CD138 positivity
MIB1 index of 80 - 90%
CD30 negativity in tumor cells
CD3 negativity in tumor cells
CD20 negativity in tumor cells
Weak positivity for CD79a
Lymphoma involving bone marrow biopsy
ALK positivity in tumor cells
Granular ALK positivity in tumor cells
ALK positive large B cell lymphoma cells
Contributed by Jennifer Chapman, M.D.
Differential diagnostic algorithm
Images hosted on other servers:
Nodules
Contributed by Jennifer Chapman, M.D.
ATLL mimicking angioimmunoblastic T cell lymphoma
ATLL with Hodgkin-like cells mimicking classical Hodgkin lymphoma
ATLL mimicking mycosis fungoides
ATLL, lymphomatous type, mimicking anaplastic large cell lymphoma
Contributed by Jennifer Chapman, M.D.
ATLL, acute variant,
mimicking
T prolymphocytic
lymphoma
Images hosted on other servers:
Flower cells
CLL-like morphology
Contributed by Jennifer Chapman, M.D.
CD45
CD4
CD56
CD7
CD25
Images hosted on other servers:
CD3+, CD4+, CD25+, CD7-, CD8-
Images hosted on other servers:
ATLL cell
Contributed by Siba El Hussein, M.D. and Joseph Khoury, M.D.
Neoplastic cells involving the bone marrow
Neoplastic cells involving the bone marrow
Immunohistochemical stains
Contributed by Siba El Hussein, M.D. and Joseph Khoury, M.D.
Flow cytometry characteristic
Contributed by Jayalakshmi Balakrishna, M.D. and Elaine S. Jaffe, M.D.
Diffuse infiltrate
Invasion of sinus
Large atypical cells
Mitotic figures and apoptotic bodies
Large atypical cells
Large atypical cells
Hallmark cells
IHC stain, CD3
IHC stain, CD4
IHC stain, CD3
IHC stain, CD25
IHC stain, Ki67
IHC stain, CD2
IHC stain, perforin
IHC stain, CD30
IHC stain, CD43
IHC stain, CD45
IHC stain, EMA
IHC stain, granzyme
Contributed by Doan Minh Khuy, M.D.
23 year old man with a cervical lymphoid nodule, no B symptoms
CK-
EMA+
ALK-
CD15-
CD20-
CD5+
Contributed by Jayalakshmi Balakrishna, M.D.
Lymph node biopsy touch preparation
Contributed by Sanam Loghavi, M.D.
CD45 and side light scatter
CD3 and CD4
CD4 and CD8
CD5 and CD2
TCR A / B
CD3 and CD30
CD4 and CD30
Contributed by Andrew Feldman, M.D.
Break apart probe FISH for chromosome region 6p25.3
Contributed by Jayalakshmi Balakrishna, M.D., Elaine S. Jaffe, M.D.
Diffuse infiltrate
Large pleomorphic cells
Large cells with pleomorphic nuclei
Large cells with pleomorphic nuclei
Large cells with pleomorphic nuclei
Mitoses and apoptosis
Intrasinusoidal infiltrate
Intrasinusoidal infiltrate
Focal infiltrate
Hallmark cells
Hallmark cells
Polymorphous background
CD3
CD3
CD30
ALK1
ALK1
ALK1
EMA
Granzyme B
CD45
Bone marrow aspirate smear
Bone marrow biopsy
Lymphohistiocytic variant
Small cell variant
Sarcomatoid variant
Contributed by Jayalakshmi Balakrishna, M.D.
Large neoplastic cells
Large neoplastic cells in polymorphous background
Contributed by Roberto N. Miranda, M.D.
Pattern I: partial nodal involvement
Pattern III: complete effacement
Pattern III: capsular involvement
Polymorphic infiltrate
Polymorphic infiltrate with eosinophilia
Bone marrow involvement
Diffuse reactivity with CD3
CD20
CD21, pattern I
CD21, pattern III
PD-1 positivity
CXCL13 positivity
CD10 in small and intermediate size lymphoma cells
CD30 positivity
Epstein-Barr virus (EBER) reactivity
Proliferation marker Ki67
CD3 reactivity in bone marrow
CD10 reactivity
Contributed by Elizabeth Courville, M.D.
Atypical monotonous lymphocyte population
Mature circulating atypical lymphocytes
Contributed by Meghan Hupp, M.D.
CLL-like
Non-CLL phenotype
Images hosted on other servers
Skin involvement
Classic jaw involvement
Contributed by Dr. Kaveh Naemi
Ileocecal valve mass
Contributed by Saja Asakrah, M.D.
Axillary lymph node
CD20
PAX5
BCL6
CD10
Ki67 positivity
BCL2
EBER in situ hybridization
Contributed by Saja Asakrah, M.D.
Blood smear, Wright-Giemsa
Contributed by Saja Asakrah, M.D.
B tube
Contributed by Saja Asakrah, M.D.
Tricolor / dual fusion FISH study
Break apart FISH study
Karyotype
Images hosted on other servers:
Mesenteric and retroperitoneal lymphadenopathy
AFIP images
Diffuse fibrosis
Numerous Hodgkin cells
Contributed by Laurence de Leval, M.D., Ph.D. and Carmen Bárcena, M.D.
Macroscopy
Contributed by Laurence de Leval, M.D., Ph.D. and Carmen Bárcena, M.D.
Nodular pattern
CD20
HRS cells
CD20
PAX5
OCT2
CD30
CD15
MUM1
CD3
PD-1
EBER in situ hybridization
Contributed by Laurence de Leval, M.D., Ph.D. and Carmen Bárcena, M.D.
Interfollicular zones
Interfollicular expansion
Reed-Sternberg / Hodgkin cells
Reed-Sternberg / Hodgkin cells and microgranulomas
Polymorphous microenvironment
Focal necrosis
CD45
PAX5
MUM1
CD30
CD15
EBER in situ hybridization
EBV LMP1
PDL1 SP263
Images hosted on other servers:
CT scan
Contributed by Béla Kajtár, M.D., Ph.D.
Paraaortic lymph nodes
Images hosted on other servers:
Splenic involvement
Contributed by Béla Kajtár, M.D., Ph.D.
Proliferation centers
Diffuse lymphocytic infiltrate
Proliferation center
CD20
LEF1
Bone marrow involvement
Contributed by Béla Kajtár, M.D., Ph.D.
Touch prep SLL
Contributed by Béla Kajtár, M.D., Ph.D.
CLL in peripheral blood
Contributed by Béla Kajtár, M.D., Ph.D.
CLL, scatter plot
Contributed by Béla Kajtár, M.D., Ph.D.
FISH images
Karyogram
Images hosted on other servers:
Reed-Sternberg cell and microenvironment
Images hosted on other servers:
PET scan before and after therapy
Images hosted on other servers:
Fleshy lymph node
Liver with multifocal involvement
Contributed by Emily Mason, M.D., Ph.D.
Hodgkin and Reed-Sternberg cells
Nodular sclerosis CHL
Scattered Reed-Sternberg cells
Lacunar cell
Syncytial variant
Weak PAX5 expression
CD30 expression
Variable CD20 expression
EBV positivity
Syncytial variant, CD30 stain
Contributed by Emily Mason, M.D., Ph.D.
Reed-Sternberg cell
Images hosted on other servers:
Reed-Sternberg cell nucleus
Images hosted on other servers:
PDL1 / PDL2 gain, amplification
Images hosted on other servers:
Composite mantle cell lymphoma and CLL / SLL
Images hosted on other servers:
Diagnostic approach
Contributed by Genevieve M. Crane, M.D., Ph.D.
High grade B cell
lymphoma with
MYC and BCL2
translocations
BCL2
Myc
Images hosted on other servers:
H&E
Contributed by Genevieve M. Crane, M.D., Ph.D.
Lack of sIg
Images hosted on other servers:
Karyotype
Contributed by Claudia Mendez, M.D.
DLBCL involving the kidney
Contributed by Matthew M. Klairmont, M.D.
Diffuse growth pattern
Cytologic features
Bone marrow involvement
Omental involvement
CD20 (bone marrow)
Contributed by Matthew M. Klairmont, M.D.
Scatter plots of splenic mass
Overview of histologic features
Images hosted on other servers:
Dysregulated NFkB signaling pathway
Images hosted on other servers:
CT pelvis and FDG PET
Contributed by Miguel Gonzalez-Mancera, M.D.
Well demarcated testicular mass
Contributed by Miguel Gonzalez-Mancera, M.D.
Diffuse infiltration
High mitotic activity
Centroblastic morphology
Immunoblastic morphology
Lymphoma infiltrating testicular parenchyma
CD20
CD10
BCL6
MUM1
Table 1: EBV viral gene expression patterns during different types of latency
| Genes | Latency III | Latency II | Latency I | Latency 0 |
| Epstein-Barr nuclear antigen 1 (EBNA1) | + | + | + | - |
| Epstein-Barr nuclear antigen 2 (EBNA2) | + | - | - | - |
| Epstein-Barr nuclear antigen 3 (EBNA3) | + | - | - | - |
| Epstein-Barr nuclear antigen (EBNA) LP | + | - | - | - |
| Latent membrane protein 1 (LMP1) | + | + | - | - |
| Latent membrane protein 2 (LMP2) | + | + | - | - |
| Epstein-Barr encoded RNAs (EBERs) | + | + | + | + |
| BHRF1 micro RNAs (miRNAs) | + | - | - | - |
| BamHI A rightward transcript (BART) micro RNAs (miRNAs) | + | + | + | + |
Table 2: Main Epstein-Barr virus serological profiles
| Anti-viral capsid antigen (VCA) IgG | Anti-viral capsid antigen (VCA) IgM | Anti-Epstein-Barr nuclear antigen (EBNA) IgG | Interpretation |
| - | - | - | Seronegative individual |
| Variable | + | - | Primary infection |
| + | - | + | Past infection |
| + | - | - | Past infection (adults) or primary infection (children) |
| + | + | + | Past infection or end of primary infection |
| - | - | + | Indeterminate |
Table 3: Viral latency type in EBV associated lymphoproliferative disorders and lymphomas
| Disease | Percentage of EBV related cases | Latency pattern | Viral proteins expressed | EBER expression pattern | ||||
| EBNA1 | EBNA2 | LMP1 | LMP2 | EBER | ||||
| B cell lymphoproliferative disorders | ||||||||
| Infectious mononucleosis | 100 | III | + | + | + | + | + | Many small and large cells are EBV+ (mainly B cells and rare positive T and NK cells); most of the EBV+ cells are present in the paracortical area |
| EBV positive mucocutaneous ulcer | 100 | I or II | + | - | + | + | + | EBV expression is variable with most cases showing scattered EBV+ cells |
| Lymphoproliferative disorders associated with immune deficiency and dysregulation | > 90 | III or II | + | + | + | + | + |
|
| T / NK lymphoproliferative disorders of childhood | ||||||||
| Hydroa vacciniforme lymphoproliferative disorder | 100 | II | + | - | + | + | + | EBV expression in around 50% of lesional cells |
| Severe mosquito bite allergy | 100 | II | + | - | - | - | + | EBV is positive in few of the lesional NK cells; a much higher density of EBV+ cells should raise suspicion of NK cell lymphoma |
| Chronic active EBV disease (CAEBVD) | 100 | II | + | - | + | + | + | EBV is uniformly expressed in many cytotoxic T cells in most cases |
| B cell lymphomas | ||||||||
| EBV positive diffuse large B cell lymphoma, NOS | 100 | II or III | + | + | + | + | + | Most of the large atypical lymphoma cells are EBV+, a cutoff of 80% has been proposed |
| Diffuse large B cell lymphoma with chronic inflammation | 100 | II or III | + | + | + | + | + | Most of the lymphoma cells are diffusely positive for EBER |
| Fibrin associated large B cell lymphoma | 100 | II or III | + | + | + | + | + | Most of the lymphoma cells are diffusely positive for EBER |
| Primary effusion lymphoma | Most of the lymphoma cells are positive for EBER in the EBV positive cases | |||||||
| HIV associated | 100 | I | + | - | - | - | + | |
| HIV unrelated | 70 - 90 | I | + | - | - | - | + | |
| Lymphomatoid granulomatosis | 100 | III | + | + | + | + | + | The large neoplastic B cells are EBV positive; the number of EBV+ cells determines the grade |
| Plasmablastic lymphoma | 60 - 75 | I | + | - | - | - | + | Most of the lymphoma cells are diffusely EBV positive |
| Burkitt lymphoma | Most lymphoma cells are positive for EBER in EBV positive cases | |||||||
| Endemic | > 95 | I | + | - | - | - | + | |
| Sporadic | 20 - 80 | I | + | - | - | - | + | |
| AIDS related DLBCL | The pattern of EBV expression coincides with the histological subtype of lymphoma occurring in the immunocompetent state | |||||||
| Immunoblastic | 70 - 100 | III | + | + | + | + | + | |
| Nonimmunoblastic | 10 - 30 | III | + | + | + | + | + | |
| CNS lymphomas | 80 - 100 | III | + | + | + | + | + | |
| Hodgkin lymphoma |
| |||||||
| EBV unrelated | 20 - 90 | II | + | - | + | + | + | |
| EBV associated | 100 | II | + | - | + | + | + | |
| EBV positive T and NK cell lymphomas | ||||||||
| Extranodal, NK / T cell lymphoma | 100 | I or II | + | - | Variable | Variable | + | Virtually all lymphoma cells are positive for EBER |
| Aggressive NK cell leukemia | 90 | II | + | - | + | + | + | Most lymphoma cells are EBV positive |
| Primary nodal EBV positive T / NK cell lymphoma | 100 | II | + | - | + | + | + | Most lymphoma cells are EBV positive |
| Systemic EBV positive T cell lymphoma of childhood | 100 | II | + | - | + | + | + | Most lymphoma cells are EBV positive |
Table 4: Differential diagnosis of EBV positive B cell lymphoproliferative disorders and lymphomas
| Features | Infectious mononucleosis | EBV+ mucocutaneous ulcer | EBV+ classic Hodgkin lymphoma | EBV+ diffuse large B cell lymphoma |
| Clinical | ||||
| Age | Young, elderly | Elderly | Young and elderly | Elderly |
| Lymphadenopathy | Present | Absent | Present, nodal or mediastinal | Present, high stage |
| LDH elevation | Present, mild to moderate | Absent | Present | Present |
| Extranodal disease | Absent | Present | Extremely rare as primary disease | Can be present, late stages |
| Clinical course | Self limited in majority of cases | Waxing and wanning | Progressive | Aggressive, poor outcome |
| Morphology | ||||
| Architecture | Paracortical | Ulcer | Effacement | Effacement |
| Circumscription | Absent | Present, lymphocytic rim at base | Absent | Absent, diffuse involvement |
| Large cells | Reed-Sternberg-like cells | Reed-Sternberg-like cells | Reed-Sternberg cells | Sheets of large neoplastic cells, some RS-like cells |
| EBV latency type | III | II / III | II | III / II |
| Immunohistochemistry | ||||
| CD45 | Positive in most cells | Positive in most cells | Negative in HRS cells | Positive in neoplastic cells |
| CD20 | Positive in large cells | Positive in large cells | Mostly negative in HRS cells, faint reactivity in HRS cells in ~20% of cases | Positive in large cells |
| PAX5 | Positive, strong | Positive, strong | Positive, weak | Positive, strong |
| BOB.1 | Positive, strong | Positive, strong | Negative, can be weak | Positive, strong |
| MUM1 | Positive | Positive | Positive | Positive |
| BCL6 | Negative | Negative | Negative | Can be positive |
| CD10 | Negative | Negative | Negative | Negative |
| CD30 | Positive in HRS-like cells, usually dim | Positive in HRS-like cells, usually dim | Positive in HRS cells, strong | Positive |
| CD15 | Positive in up to 50% of cases | Positive in up to 50% of cases | Positive, variable | Positive in up to 50% of cases |
| PDL1 | Negative | Negative | Positive in > 80% | Can be positive (40 - 60%, extranodal) |
| Diagnostic molecular testing | ||||
| B cell | Polyclonal | Clonal in 50% of the cases | Clonal | Monoclonal IGH gene rearrangements |
| T cell | Polyclonal | Oligoclonal and restricted TCR rearrangement patterns | Polyclonal, restricted pattern in elderly patients | Oligoclonal and restricted TCR rearrangement patterns |
| Genetic features | No immune evasion features | No immune evasion features | Immune evasion (host evasion) | Immune evasion (host evasion) |
Table 5: Differential diagnosis of EBV positive T and NK lymphomas
| Feature | Extranodal NK / T cell lymphoma | Aggressive NK cell leukemia | EBV positive nodal T and NK cell lymphoma | Systemic EBV+ T cell lymphoma of childhood |
| Clinical presentation | ||||
| Age | Adults | Young to middle aged adults | Older adults | Children, young adults |
| Site at presentation | Nasopharynx (70 - 80%), others (20 - 30%): skin, gastrointestinal (GI) | Bone marrow, spleen, peripheral blood, rarely lymph nodes (20%) | Lymph nodes, no nasal involvement by definition | Systemic proliferation: bone marrow, liver or spleen, CNS |
| Behavior | Localized disease, frequent dissemination | Fatal | Aggressive | Fulminant |
| Median survival | 26 - 76 months | Weeks | 4 months | Days to weeks |
| Hemophagocytic syndrome | Generally absent | Present | Uncommon | Always present |
| Morphology | ||||
| Cytology of neoplastic cells | Variable atypia, spectrum from small to large cells | Large granular atypical lymphocytes, distinct nucleoli and clear cytoplasm (smears) | Pleomorphic medium sized cells, with centroblastic, anaplastic or plasmacytoid features | Small to intermediate sized with subtle to absent atypia (most common) or large atypical cells |
| Necrosis | Common | Frequently present | Variable | Absent |
| Angiocentricity and angiodestruction | Present | Frequently present | Uncommon | Absent |
| Apoptosis | Present | Frequently present | Variable | Absent |
| Ancillary testing | ||||
| CD2 | Positive | Positive | Positive | Positive |
| CD3 | Often negative; subset is positive | Negative | Positive | Positive |
| CD3ε | Positive | Positive | Positive | Positive |
| CD4 | Negative | Negative | Negative | Usually negative |
| CD8 | Positive | Usually negative | Positive (> 80%) | Usually positive |
| CD56 | Positive | Positive | Mostly negative (positive < 20%) | Negative |
| Cytotoxic granules | Positive | Positive | Positive | Positive |
| EBER | All neoplastic cells | All neoplastic cells, a subset is negative (< 15%) | All neoplastic cells | Majority of neoplastic cells |
Table 6: Differential diagnosis of EBV+ B cell lymphoproliferations with Hodgkin-like features
| Disease | Clinical features | Morphology | Immunophenotype | Lineage, clonality and molecular features |
| EBV+ mucocutaneous ulcer |
|
|
|
|
| EBV+ diffuse large B cell lymphoma, NOS |
|
|
|
|
| EBV+ classic Hodgkin lymphoma |
|
|
|
|
Contributed by Francisco Bravo, M.D.
Hydroa
vacciniforme
lymphoproliferative
disorder
Contributed by Roberto N. Miranda, M.D. and Roman Segura-Rivera, M.D.
Infectious mononucleosis in an excised lymph node
Interfollicular expansion in infectious mononucleosis
Infectious mononucleosis
Infectious mononucleosis
Follicular hyperplasia arising in immune deficiency / dysregulation
Germinal center reaction
Hydroa vacciniforme
Hemophagocytic
lymphohistiocytosis
EBV positive plasmablastic lymphoma
Extranodal NK / T cell lymphoma showing angiocentricity
Extranodal NK / T cell lymphoma
Extranodal NK / T cell lymphoma in the intestine
Contributed by Roberto N. Miranda, M.D. and Roman Segura-Rivera, M.D.
Downey cells
Contributed by Sudhir Perincheri, M.B.B.S., Ph.D.
Polymorphic type
Reed-Sternberg-like cells
CD20
EBER
Monomorphic type
Necrosis
Images hosted on other servers:
Differentiating characteristics of EBV+ DLBCL and EBVMCU
Contributed by Sergio Pina-Oviedo, M.D.
Surface ulceration and necrosis
Atypical cells with Hodgkin / RS cell-like morphology
EBER ISH positive in atypical cells
CD20 positive B cells
CD3 positive T cells
Contributed by Carlos A. Murga-Zamalloa, M.D.
Diffuse atypical infiltrate
Morphological atypia
Pleomorphic infiltrate
Pleomorphism and marked cellular atypia
EBV positive lymphocytes (EBER in situ hybridization)
Contributed by Roberto N. Miranda, M.D.
Ileocecal ulcer
Ileocecal infiltration
Angiocentric and angioinvasive lesion
Mucosal and submucosal infiltration
Cytologic atypia
Intraepithelial lymphocytes
Sinusoidal infiltration
Sinusoidal CD30 positivity
CD3 positivity
CD30 positivity
CD4 negativity
CD8 negativity
TIA1 positivity
Contributed by Auris Huen, M.D.
Skin lesion
Contributed by Roberto N. Miranda, M.D. and Carlos A. Torres-Cabala, M.D.
Nasal lesion of ENKTCL
Diffuse infiltrate
Cytological atypia
EBER positivity
Angioinvasion in ENKTCL
Atypical infiltrate in skin
CD3 positivity
CD7 positivity
CD56 positivity
Perforin positivity
Hemophagocytosis
ENKTCL NT in bone marrow
Bone marrow CD3
Bone marrow EBER
Skin involvement by PTCL, NOS
Cytological atypia in PTCL, NOS
T cell LGL leukemia
CD3 in T cell LGL
CD57 in T cell LGL
TIA1 in T cell LGL
Skin in EBV+ DLBCL
CD20 in DLBCL
EBER in DLBCL
Necrosis in tuberculosis
Necrosis in histoplasmosis
Histoplasmosis GMS stain
Contributed by Jordan M. Hall, M.D., Hyunkyu Shin, M.D., Dr. Christian Schürch, M.D., Ph.D., Falko Fend, M.D. and Claudia Wickenhauser, M.D., Ph.D. (Case #529)
Knee synovium
Knee joint space fibrin
PAX5
CD30
Ki67
EBER ISH
H&E staining
H&E staining
CD138
MUM1
CD3
CD20
CD79a
ALK
MYC
HHV8
Kappa
Lambda
Cyclin D1
CD56
EBER
BCMA
Contributed by Abdallah Flaifel, M.D.
Cell block TdT
Images hosted on other servers:
Schematic of a flow cytometer
Contributed by Abdallah Flaifel, M.D.
Pericardial fluid cytospin
Cell block TdT
Contributed by Nicholas Ward, M.D.
B ALL flow cytometry
B ALL flow cytometry
Contributed by Carlos A. Murga-Zamalloa, M.D.
Cell block preparation
Cell block preparation (CD20)
Cell block preparation (MUM1)
Cell block preparation (HHV8)
Cytospin preparation (Wright-Giemsa)
| Nodal Follicular Lymphoma | Duodenal Follicular Lymphoma |
| Grade 1 - 2 or 3 | Grade 1 - 2 |
| Stage III or IV | Stage I or II |
| BCL2, CD10, BCL6: Positive | BCL2, CD10, BCL6: Positive |
| AID: Positive | AID: Negative |
| CD21 stain: Dense stain in the center of germinal center of follicles |
CD21 stain: Accentuated staining at the periphery of germinal center of follicles |
| BCL2 and BCL6 rearrangements: + | BCL2 and BCL6 rearrangements: + |
| CREBBP mutations present | CREBBP mutations present |
| KMT2D mutations present | Lower KMT2D mutations present |
Contributed by Mahsa Khanlari, M.D.
Small intestinal polyp
CD10 and CD20 Immunohistochemistries
BCL2 IHC
CD21 IHC
Contributed by @ahmsab_MD on Twitter
Duodenal type follicular lymphoma
Images hosted on other servers:
Development of follicular lymphoma-like B cells
Contributed by Elaine S. Jaffe, M.D.
H&E overview
BCL2 overview
CD10 overview
H&E neoplastic follicle
BCL2 neoplastic follicle
CD10 neoplastic follicle
H&E reactive follicle
BCL2 reactive follicle
CD10 reactive follicle
Contributed by Nicholas Ward, M.D. and Roberto N. Miranda, M.D.
Mixed histology pattern
Atypical lymphoid aggregates
CD3
CD20
PD-1
ICOS
CD10
IgD
Neoplastic lymphocytes
CD3
CD20
CD21
PD-1
Images hosted on other servers:
T cells expressing CD4 without surface CD3 (n, o, p, q)
Significant population of CD3- / dim CD4+ T cells (b, c)
Images hosted on other servers:
FISH for the detection of t(5;9)(q33;q22)
5' and 3' RACE identifies ITK-SYK fusion
| World Health Organization grading of follicular lymphoma | |||
| Grade | Definition | Pattern | Immunohistochemistry and cytogenetics |
| 1 | 0 - 5 centroblasts/high power field | Follicular or diffuse |
IHC: CD10: + (95 - 100%) BCL2: + (85 - 90%) FISH: BCL2 translocation: + (80 - 90%) BCL6 rearrangement: + (3%) Ki67: < 20%* |
| 2 | 6 - 15 centroblasts/high power field | Follicular or diffuse | |
| 3A | > 15 centroblasts/high power field Centrocytes present | Follicular If diffuse component: Reported as diffuse large B cell lymphoma and follicular lymphoma (% of each component is reported); correlate with clinical features and overall grade in cases with small areas of diffuse pattern |
IHC: CD10: + (80 - 95%) BCL2: + (50 - 75%) FISH: BCL2 translocation: + (60 - 70%) BCL6 rearrangement: + (30 - 40%) Ki67: > 20% |
| 3B | > 15 centroblasts/high power field Lack centrocytes | Follicular If diffuse component: Reported as diffuse large B cell lymphoma and follicular lymphoma (% of each component is reported) |
IHC: CD10: + (40 - 85%) BCL2: + (45 - 75%) FISH: BCL2 translocation: + (15 - 30%) BCL6 rearrangement: + (40 - 50%) CD10-IRF4/MUM1+: common Ki67: > 50% |
Notes:
- IHC: immunohistochemistry
- FISH: fluorescence in situ hybridization
- High power field of 0.159 mm2 (40× objective)
- Follicular: > 75% (proportion follicular %)
- Diffuse: 0% (proportion follicular %)
- * ~20% of low grade follicular lymphomas have a high proliferation (Ki67) rate (Am J Surg Pathol 2005;29:1490)
- References: Arch Pathol Lab Med 2018;142:1330, Haematologica 2018;103:1182, Swerdlow: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Edition, 2017
Contributed by Jennifer Chapman, M.D.
Follicular lymphoma
Back to back follicles
Mantle zone
Low grade morphology
CD20
CD3
Germinal center markers (CD10 and BCL6)
BCL2
Follicular dendritic cell meshworks
High grade morphology
Paratrabecular pattern of involvement in bone marrow
Contributed by Mahsa Khanlari, M.D.
Fine needle aspirate smear
Contributed by Jennifer Chapman, M.D.
Peripheral blood smear involvement
Contributed by Mahsa Khanlari, M.D.
Flow cytometric immunophenotyping
Flow cytometric immunophenotyping, monotypic population
Contributed by Mahsa Khanlari, M.D.
IGH-BCL2 dual color FISH
Contributed by Annapurna Saksena, M.B.B.S, M.D. and Elaine S. Jaffe, M.D.
Diffuse growth pattern
Atypical large lymphoid cells
Multicentric Castleman disease
Multicentric Castleman disease, HHV8
HHV8 LANA positive atypical cells
HHV8 LANA nuclear staining
EBER ISH negative atypical cells
Contributed by Julie Teruya-Feldstein, M.D.
Follicles of varying sizes
Hyalinization in some follicles
Plasmablasts
EBER1
Plasmablasts positive for MUM1
Plasmablasts negative for CD30
Plasmablasts negative for BCL6
Plasmablasts negative for CD10
Plasmablasts negative for CD79a
Contributed by Buthaina Al-Maashari, M.D. and Dietrich Werner, M.D.
Bone marrow core biopsy
BRAF IHC
Images hosted on other servers:
Lymph node FNA
Contributed by Buthaina Al-Maashari, M.D. and Dietrich Werner, M.D.
Circulating hairy cell
Images hosted on other servers:
Typical leukemic cell in hairy cell leukemia
Contributed by Buthaina Al-Maashari, M.D. and Dietrich Werner, M.D.
Peripheral blood analysis of a 67 year old man with cytopenias
Peripheral blood analysis of a 67 year old man with cytopenias
Contributed by Pallavi Khattar, M.D. and Case #437
Bone marrow biopsy
CD20 immunostain
Bone marrow aspirate
Bone marrow aspirate
Bone marrow biopsy
Bone marrow aspirate
Bone marrow aspirate
CD20 immunostain
CD3 immunostain
DBA-44 immunostain
Contributed by Roberto N. Miranda, M.D.
Bone marrow infiltration
Bone marrow with dyspoietic changes
CD3 positive
CD4 negative
CD8 negative
TCR βF1 negative
TCRγδ positive
Liver infiltration
HSTCL: CD3 positive
HSTCL: CD4 negative
CD8 positive
TIA1 positive
Small size morphology
Intermediate size morphology
Blastic morphology
Contributed by Roberto N. Miranda, M.D.
Positivity for CD2, TCRγδ and CD56
Images hosted on other servers:
Diagnostic approach
Contributed by Jon C. Aster, M.D., Ph.D. and Genevieve M. Crane, M.D., Ph.D.
Oropharyngeal mass
CD10
MYC
Ki67
HGBL, NOS
High Ki67
Contributed by Kyle Bradley, M.D.
Mantle zone and interfollicular involvement
Early lymph node involvement by mantle cell lymphoma
Follicular lymphoma with concurrent in situ mantle cell neoplasia
Contributed by Jinjun Cheng, M.D., Ph.D.
Large granular lymphocytosis
- Not relevant to this topic
- Not available
- Not relevant to this topic
- Not available to this topic
Contributed by Barina Aqil, M.D.
Atypical lymphoid infiltrate
Positive for CD3
Negative for CD4
Negative for CD8
Positive for CD56
Negative for EBER
- Not relevant to this topic
- Not relevant to this topic
- Not available
- Not available
- Not available
- Not available
Contributed by Anamarija M. Perry, M.D.
Colon with indolent T-LPD
Infiltration of lamina propria
Atypical infiltrate of indolent
T-LPD
CD8 IHC stain
CD4 IHC stain
TIA1 IHC stain
Contributed by Carlos A. Murga-Zamalloa, M.D.
Epitheliotropism of atypical infiltrates
Infiltrates adjacent to ulcer site
Submucosal extension of infiltrates
CD3 positive infiltrates
Aberrant CD5 loss
Contributed by Kathryn Gibbons, M.D.
ILBCL involving skin and subcutaneous tissue
Large lymphoma cells in small vessels
ILBCL involving the brain parenchyma
Vessel with involvement by ILBCL
Large lymphoma cells in the vessels
CD20
BCL6
MUM1
Contributed by Jayalakshmi Balakrishna, M.D.
Diffuse pattern
Expansile follicles
Diffuse effacement
with medium
sized cells
Medium sized atypical lymphoid cells
Round to irregular nuclear contours and conspicuous nucleoli
Follicular pattern
CD20
BCL2
BCL6
MUM1
CD21
Contributed by Itziar Salaverria, Ph.D.
FISH break apart probe for IRF4
Contributed by Anna Shestakova, M.D., Ph.D.
Diffuse lymph node infiltration by lymphoma cells
Interspersed tingible body macrophages
Atypical lymphoma cells
CD20 stain
CD10 stain
BCL6 stain
Ki67 stain
Contributed by Nicholas Joseph Dcunha, M.B.B.S., M.D. and Elanthenral Sigamani, M.B.B.S., M.D.
Mass in lung (CT scan)
Contributed by Nicholas Joseph Dcunha, M.B.B.S., M.D. and Elanthenral Sigamani, M.B.B.S., M.D.
Lymphocytic vasculitis with angioinvasion (lung)
CD20 in tumor cells and CD3
CD30 and EBV LMP1 IHC
Lymphocytic vasculitis with angioinvasion (skin)
CD20 and CD30 in tumor cells; CD3 and CD4 in reactive T cells
Lymphocytic vasculitis with angioinvasion (CNS)
CD20 and EBV LMP1 in tumor cells; CD3 in reactive T cells
Contributed by Ling Zhang, M.D.
Increased lymphoid cells
Round eccentrically located nuclei
Condensed chromatin, inconspicuous nucleoli
Small mature lymphoid cells
Intermingled plasma cells
Lymphoid cells negative for CD3
Diffuse CD20 positivity
Focal plasma cell positivity (CD138)
Immunoglobulin M positivity
Contributed by Ling Zhang, M.D. and Caroline An, M.D.
Kappa clonal population of B cells
CD38+ / CD138+ plasma cells
Lambda restriction
Plasma cells express CD45
Presence of CD19
Presence of CD20 expression
B cells expressing both CD19 and CD20
B cells are lambda monoclonal
B cells show variable expression for CD38
Contributed by Ling Zhang, M.D.
ISH clonal kappa light chain expression
Negative lambda light chain expression
Contributed by Roberto N. Miranda, M.D.
Salivary gland lymphoepithelial lesion
Cytokeratin and lymphoepithelial lesion
CD20 positivity in salivary gland lymphoepithelial lesion
Gastric gland lymphoepithelial lesion
Thyroid gland MALT lymphoma
PCMZL
PCMZL subepidermal lesion
PCMZL - CD20 positive
PCMZL - CD3 negative
Lung BALT lymphoma
Lymphoepithelial lesion of the stomach
Stomach MALT lymphoma
Lambda light chain restriction
Kappa negativity
Breast MALT lymphoma
CD10 negativity in MALT lymphoma
BCL6 negativity in MALT lymphoma
Contributed by Chi Young Ok, M.D.
Monotonous immature cells
PAX5 immunohisto-
chemical stain
CD5 immunohisto-
chemical stain
Proliferation index, Ki67
Follicular dendritic cell meshwork
Large cells with variable sizes
Cyclin D1 immunohisto-
chemical stain
p53 pattern of staining
Diffuse involvement of bone marrow
Contributed by Patricia Tsang, M.D., M.B.A. (Case #499)
Abdominal wall mass
PAX5
CD5
Ki67
Cyclin D1
SOX11
Contributed by Chi Young Ok, M.D.
Immature monotonous cells in cytology
Contributed by Chi Young Ok, M.D.
Lymphoma cells in peripheral blood
Contributed by Chi Young Ok, M.D.
Complex karyotype
Deletion of TP53 gene
Contributed by Chi Young Ok, M.D.
Monotonous population of small lymphoid cells
Follicular localization of lymphoid cells
Spleen involvement
Cyclin D1 expression
Mantle zone pattern
Pink histiocytes
Cyclin D1 and SOX11 in mantle zone pattern
Ki67 in mantle zone pattern
Bone marrow involvement
Follicular dendritic cell meshwork
Contributed by Chi Young Ok, M.D.
Small to intermediate centrocytes in cytology
Contributed by Chi Young Ok, M.D.
Atypical mature cell in peripheral blood
Contributed by Chi Young Ok, M.D.
Abnormal FISH result
Abnormal karyotype result
Contributed by Nicholas Nowacki, M.D.
Lymphoid infiltrate
Small lymphoma cells
Marrow aspirate
CD3 highlights T cells
CD5 positive
CD20 positive
Cyclin D1 positive
SOX11 negative
Contributed by Nicholas Nowacki, M.D.
Peripheral blood
Contributed by Nicholas Nowacki, M.D.
Aberrant CD5 coexpression
CD20 moderate expression
Surface light chain restriction
Contributed by Anamarija M. Perry, M.D.
Lymph node with nodal marginal zone lymphoma (NMZL)
Atypical infiltrate
Lymph node with pediatric NMZL
CD20 stain
CD10 stain
BCL2 stain
Ki67 stain
PAX5 stain in pediatric NMZL
IgD stain in pediatric NMZL
Contributed by Elaine S. Jaffe, M.D. and João Víctor Alves de Castro, M.D.
MGZL key features
Images hosted on other servers:
Large anterior mediastinal mass
Contributed by Elaine S. Jaffe, M.D. and João Víctor Alves de Castro, M.D.
Tumor nodules
Tumor cell richness
Cytologic spectrum
Widespread CD30 positivity
CD15 positivity
Lack of CD20 expression
Widespread CD19 positivity
Weak CD79a expression
PAX5 expression
CD23 expression
Contributed by Xiaoling Guo, M.D., Ph.D. and Yanhua Wang, M.D.
CT abdomen and pelvis
Contributed by Xiaoling Guo, M.D., Ph.D. and Yanhua Wang, M.D.
Ulcerated mass
Cross section of the mass
Contributed by Xiaoling Guo, M.D., Ph.D. and Yanhua Wang, M.D.
Uninvolved mucosa
Mucosa overlying the mass
Monomorphic transmural lymphocytic infiltrate
CD3
CD7
CD8
Granzyme B
TIA1
CD20
Ki67
Images hosted on other servers:
Characteristic immunophenotype
Immunophenotypic comparison
Contributed by Catalina Amador, M.D.
Effacement of nodal architecture
Medium to large sized lymphocytes
Clear cell morphology
CD21 and CD23: absent expansion of follicular dendritic cell meshworks
CD20 negative for B cell markers
Positive membranous expression of CD4
ICOS membranous positivity
PD-1 membranous positivity
BCL6 nuclear positivity
Contributed by Elaine S. Jaffe, M.D., Jayalakshmi Balakrishna, M.D. and Lauren B. Smith, M.D.
Vaguely nodular architecture
Rare large neoplastic cells
Lymphocyte predominant (LP) cells (popcorn cells)
Effaced lymph node architecture
Neoplastic cells positive for CD20
T cell rich variant with rare small B cells in the background
Neoplastic cells positive for CD20
OCT2 stain is helpful to highlight neoplastic cells
Neoplastic cells positive for PAX5
Neoplastic cells positive for BCL6
IgD expressing LP cells
T cell rosettes around LP cells
CD4 T cells predominate in the background
T cells express PD-1
PD-1 positive T cells form rosettes around LP cells
Expanded follicular dendritic cell meshwork
LP cells express CD20
Contributed by Elaine S. Jaffe, M.D., Jayalakshmi Balakrishna, M.D. and Lauren B. Smith, M.D.
Vaguely nodular architecture
Rare large neoplastic cells
Lymphocyte predominant (LP) cells (popcorn cells)
Effaced lymph node architecture
Neoplastic cells positive for CD20
T cell rich variant with rare small B cells in the background
Neoplastic cells positive for CD20
OCT2 stain is helpful to highlight neoplastic cells
Neoplastic cells positive for PAX5
Neoplastic cells positive for BCL6
IgD expressing LP cells
T cell rosettes around LP cells
CD4 T cells predominate in the background
T cells express PD-1
PD-1 positive T cells form rosettes around LP cells
Expanded follicular dendritic cell meshwork
LP cells express CD20
Contributed by Cade Arries, M.D.
Bone marrow
Bone marrow, CD30
Bone marrow, CD15
Bone marrow, EBER
Lymph node
Lymph node
Lymph node, CD15
Lymph node, CD30
Lymph node, PAX5
Lymph node, EBER
Contributed by Daniel Cassidy, M.D. and Jennifer Chapman, M.D.
Architectural distortion
Polymorphic lymphoid infiltrate
Full spectrum of maturation
Composition of lymphoid infiltrate
Polymorphic infiltrate
Variably sized B cells
PAX5 variable cell size
Variably sized T cells
Scattered immunoblasts
EBER positivity
Contributed by Kathryn Gibbons, M.D.
Lymph node with pediatric nodal marginal zone lymphoma
Atypical infiltrate
CD20 stain
PAX5 stain
CD43 stain
IgD stain
Pediatric type follicular lymphoma versus follicular lymphoma usual type
| Pediatric type FL | Usual type FL | |
| Age | Young | Old age (sixth decade) |
| Stage | Low (I - II) | High (III - IV) in majority of cases |
| Location | Head and neck | Variable |
| Extranodal location | Absent | Present, variable |
| Histology | Grade 3 | Grade 1 - 3 |
| BCL2 (IHC) | Negative / dim | Usually positive |
| CD10 | Positive (~100%) | Positive (usually) |
| Ki67 | High | Low (except for high grade) |
| t(14;18) IGH-BCL2 | Absent | Present, up to 90% |
| Monotypic B cells by flow cytometry | Frequent | Frequent |
| Monoclonal IgH rearrangements | Frequent | Frequent |
| BCL6 or MYC rearrangements | Absent | Variably present |
| Genetic | 1p36 loss | Complex, variable |
| Mutations | TNFRSF14, MAP2K1, IRF8 (K66R) | CREBBP, EZH2, KMT2D |
| Prognosis | Favorable | Variable |
Contributed by L. Jeffrey Medeiros, M.D. and Mahsa Khanlari, M.D.
Lymph node in 23 year old man
IHC for CD20
IHC for CD10
IHC for BCL6
IHC for BCL2
IHC for IgD; attenuated and focally absent mantle zone
Images hosted on other servers:
A, B: monomorphic morphology
characteristic of GATA3 subtype
C, D: polymorphous morphology
characteristic of TBX21 subtype
Contributed by Matthew M. Klairmont, M.D.
PTCL, NOS
PTCL, NOS involving the skin
Images hosted on other servers:
Imprints of PTCL, NOS (lymphoepithelioid / Lennert variant)
Contributed by Julio Poveda, M.D.
Intermediate to large sized cells
CD138
CD20
MUM1
Images hosted on other servers:
Landscape using WES
Images hosted on other servers:
Immunodeficiency
associated LPDs
in WHO-HAEM4R
and WHO-HAEM5
3 part nomenclature
for immunodeficiency
associated LPDs
Contributed by Miguel Gonzalez-Mancera, M.D.
Heterogeneous infiltrate
Heterogeneous infiltrate
Gastrointestinal biopsy
CD3
CD20
CD68
MUM1
Kappa light chain
Lambda light chain
EBV EBER
LMP1
Images hosted on other servers:
Brain MRI with contrast enhancing lesion
Solid and enhancing nodules on MRI
Images hosted on other servers:
Cerebral lymphoma
spreading across
the corpus callosum
Contributed by Elizabeth Courville, M.D. and Lena Young, D.O.
Perivascular infiltrate of atypical lymphoid cells
Diffuse infiltrate
of intermediate
to large
mononuclear cells
Cytology of mononuclear cells
Perivascular cuffing by neoplastic lymphocytes
Infiltrate of neoplastic intermediate to large lymphocytes with background inflammation and necrosis
Pleomorphic lymphocytes infiltrating brain
Immunohisto-
chemistry for B and T cells
ISH shows lambda restriction
Contributed by Jennifer Chapman, M.D.
Dense dermal infiltrate
Predominantly small to medium sized lymphocytes
Scattered large cells
Most cells show strong CD3 expression
Most cells show strong CD4 expression
Numerous cells show strong PD1 expression
Subset of abnormal cells show strong ICOS expression
Small CD8+ T cells
Contributed by Roberto N. Miranda, M.D.
Skin epidermotropism and dermal infiltrate
Epidermotropism with intraepidermal cluster
Lymphoma at the dermoepidermal junction
Large pleomorphic cells
CD3 positivity
CD4 negativity of epidermotropic cells
CD7 positivity of epidermotropic cells
CD8 positivity of epidermotropic cells
TIA1 positivity of lymphoma cells
Proliferation marker Ki67
Pagetoid reticulosis
Microabscess of Pautrier in pagetoid reticulosis
CD3 in pagetoid reticulosis
CD8 in pagetoid reticulosis
βF1 pagetoid reticulosis
Folliculotropism in CD8 epidermotropic TCL
Epidermotropism in CD8 epidermotropic TCL
Epidermotropic small lymphoma cells
Liver involvement by CD8 cytotoxic TCL
CD3 positive lymphoma cells
CD8 positive lymphoma cells
Contributed by Roberto N. Miranda, M.D.
Erythematous ulcerated tumor mass lesions
Contributed by Roberto N. Miranda, M.D.
Atypical dermal infiltrate
Absent or minimal epidermotropism
CD3 positive
CD4 positive
CD8 negative
Partial loss of CD7
CD30 negative
Atypical lymphoid infiltrate
TCR βF1 positive
TCR delta negative
Contributed by Roberto N. Miranda, M.D. and Alexandra Hristov, M.D.
Dermal infiltrate with grenz zone
Morphology of infiltrates
Characteristic CD68 staining
Cytotoxic immunophenotype
Contributed by Roberto N. Miranda, M.D.
Ulcerated tumors
Erythematous plaques
Contributed by Roberto N. Miranda, M.D.
Diffuse infiltrate
Epidermotropic infiltrate
Fat rimming
Cytologic atypia
TCR alpha beta negativity
Pagetoid pattern
Hemophagocytosis
CD3 positivity
CD4 loss
CD4 negativity (CD4 loss)
CD7 negativity (CD7 loss)
CD8 positivity
TIA1 positivity
TCR delta positivity
TCR beta chain negativity
Contributed by Roberto N. Miranda, M.D.
TCR gamma delta positivity
TCR gamma delta
positivity and
TCR alpha beta
chain negativity
Contributed by Mario L. Marques-Piubelli, M.D. and Roberto N. Miranda, M.D. (Case #519)
Extracavitary presentation of PEL
EBER
LANA1
LANA1 in an extracavitary presentation
Contributed by Barina Aqil, M.D., Mario L. Marques-Piubelli, M.D. and Roberto N. Miranda, M.D. (Case #519)
Pleomorphic cells
Negative for CD19
Negative for CD20
Negative for PAX5
Positive for CD138
Positive for kappa ISH
Negative for lambda ISH
Abnormal large pleomorphic cells
Large plasmacytoid cells
Diff-Quik
Wright-Giemsa
ThinPrep
Clinical features:
| Nodal follicular lymphoma | Testicular follicular lymphoma | |
| Age (median) | Adults and elder (sixth decade) | Children and young adults |
| Gender (M:F) | Men and women | Men only |
| Affected sites | Lymph nodes with extranodal spread | Testicle and adnexa |
| Symptoms | Generalized lymphadenopathy | Painless mass |
| Stage (Ann Arbor) | High (III - IV) in most cases | IE |
Pathologic features:
| Nodal follicular lymphoma | Testicular follicular lymphoma | |
| Gross appearance | Discrete mass or complete effacement | Discrete mass or diffuse involvement |
| Histologic grade | Grades 1 - 3 | Grade 3 |
Immunophenotype:
| Nodal follicular lymphoma | Testicular follicular lymphoma | |
| CD10 | Variable | Variable |
| BCL2 | Usually positive | Negative |
Molecular features:
| Nodal follicular lymphoma | Testicular follicular lymphoma | |
| IGH-BCL2 | Present, up to 90% | Negative |
Contributed by Roberto N. Miranda, M.D.
Follicular lymphoma of testis
Seminiferous tubuli and neoplastic follicle
Large centroblasts of follicular lymphoma
BCL6 IHC
CD21 IHC
DLBCL of testis
Contributed by Jennifer Chapman, M.D.
Intermediate to large sized cytologically atypical lymphoid cells
Diffuse distribution of intermediate to large sized lymphoma cells
Endobronchial biopsy
Endobronchial biopsy
CD19
CD20
CD23
CD30
Contributed by Mahsa Khanlari, M.D.
Papanicolaou
Contributed by Richard K. Wood, M.D. and Dietrich Werner, M.D.
Bone marrow involvement
CD20 positivity in bone marrow
CD79a positivity in bone marrow
Cyclin D1 negativity in bone marrow
Contributed by Allam Shawwa, M.D.
Prolymphocytes in peripheral blood
Prolymphocytes in peripheral blood
Contributed by Shahbaz Khan, M.D. and Sepideh Nikki Asadbeigi, M.D.
Diffuse large B cell lymphoma type
Extranodal
Contributed by Roberto N. Miranda, M.D.
Prominent exfoliative lesion
Prominent erythroderma
Contributed by Roberto N. Miranda, M.D.
Central nervous system (CNS) involvement
Contributed by Roberto N. Miranda, M.D.
Bone marrow involvement
CD3 positivity
Epidermotropic and lichenoid lymphoid infiltrate
Epidermotropic infiltrate
Cerebriform cytology
Lymph node involvement
Cytological atypia
Contributed by Roberto N. Miranda, M.D.
Lymph node touch print
Contributed by Roberto N. Miranda, M.D.
Cerebriform lymphocytes in peripheral blood smear
Contributed by Roberto N. Miranda, M.D.
Flow cytometry in SS
Contributed by Eberth Quijano, M.D. and Natalia Soto, M.D.
Skin at the mosquito bite site
Ulcer at mosquito bite site
Contributed by Carlos Barrionuevo-Cornejo, M.D., Ph.D.
Perivascular dermal infiltrates
Ulceration of skin
Subcutaneous adipose lymphocytic infiltrates
Perivascular and angiocentric infiltrates
Vascular necrosis
Small to medium atypical lymphocytes
CD3 positive atypical cells
CD56 positive atypical cells
Granzyme B positivity
EBER in situ hybridization
Contributed by Maria Paz Gray, M.D.
Massively enlarged spleen with SBLPN
Contributed by Dennis O’Malley, M.D. and Maria Paz Gray, M.D.
SDRPL infiltrating the spleen
SBLPN infiltrating the spleen
SBLPN infiltrating spleen sinusoids
SBLPN infiltrating the bone marrow
SBLPN
infiltrating
spleen sinusoids,
CD20 immunostain
SBLPN
infiltrating the
bone marrow,
CD20 immunostain
Contributed by Dennis O’Malley, M.D.
Peripheral blood with SBLPN
Contributed by Anamarija M. Perry, M.D.
SBLPN: CD19 and CD20
SBLPN: kappa light chain
SBLPN: CD22 and CD11c
SBLPN: CD103 and CD25
Images hosted on other servers:
Diffusely enlarged spleen
Images hosted on other servers:
Neoplastic villous lymphocytes
Body regions
Lymph node regions
TNMB classification of MF / SS
Lymph node grading
TNM classification of non-MF / SS
Contributed by Henry K. Wong, M.D., Ph.D.
Mycosis fungoides, patch stage
Mycosis fungoides, plaque stage
Mycosis fungoides, tumor stage
Images hosted on other servers:
Sézary cells, peripheral smear
Diagnosis and staging of cutaneous lymphoma
Contributed by Roberto N. Miranda, M.D.
Subcutaneous uptake
Contributed by Roberto N. Miranda, M.D.
Subcutaneous lesions
Subcutaneous plaque
Contributed by Roberto N. Miranda, M.D.
Deep dermis and subcutaneous involvement
Epidermis and reticular dermis sparing
Lobular distribution
Acellular hyaline change
Adipocyte rimming
CD8 positivity
CD4 negativity
TIA1 positivity
βF1 (TCRα / β) positivity
TIM-3 positivity
Contributed by Yoon Kyung Jeon, M.D.
Lymphocytic infiltrates in the liver
Lymph node, atypical infiltrates
Lymph node, atypical infiltrates
Lymphocytic infiltrates in the liver (CD3)
Images hosted on other servers:
PCR for TCR gamma gene
Contributed by Elaine Jaffe, M.D. and João Víctor Alves de Castro, M.D.
Proposed interrelatedness of EBV positive T / NK LPDs
Images hosted on other servers:
Muscle involvement and coronary artery dilation
Contributed by Elaine Jaffe, M.D. and João Víctor Alves de Castro, M.D.
Spleen, red and white pulp
Lymphoid aggregate in the red pulp
Hemophagocytosis
EBER positive T cells in spleen
Ulcerative lesion
Perivascular and periadnexal involvement
Follicular and paracortical hyperplasia
Paracortical hyperplasia
Dense CD3 positive infiltrate
TCR delta positive infiltrate
EBER positive T cells in lymph node
CD3 in the red pulp
CD8 positive T cells
Images hosted on other servers:
NK cells with abnormal phenotype in the bone marrow
Contributed by Konrad Chan, M.D.
NLPHL versus THRLBCL
CHL versus THRLBCL
Contributed by Aaron Auerbach, M.D., M.P.H., Asmaa Gaber Abdou, M.D. and Nancy Youssef Asaad, M.D.
Scattered large atypical cells
Large neoplastic cells
CD20 in a biopsy
CD20 in an excision
CD3+ small T cells
CD68+ histiocytes
Contributed by Contributed by Mingyi Chen, M.D., Ph.D. (Case #317)
CD3
CD20
PAX5
CD30
NLPHL versus THRLBCL
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
T LGLL bone marrow involvement
Intrasinusoidal CD3+ T LGLL
Intrasinusoidal CD8+ T LGLL
Intrasinusoidal granzyme B+ T LGLL
Intrasinusoidal TIA1+ T LGLL
T LGLL liver involvement
CD8+ T LGLL in liver
CD5- T LGLL in liver
TIA1+ T LGLL in liver
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
T LGLL in peripheral blood
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
T LGLL flow cytometry
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
Diffuse bone marrow involvement
Splenic red pulp infiltrate
Monotonous, paracortical lymphoid infiltrate
Intermediate size, atypical lymphocyte
CD3 positivity in bone marrow
Monotonous T cell infiltrate
TCL1A positivity
Uniform strong TCL1A staining
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
Cerebriform variant
Prolymphocytes in peripheral blood
Small cell variant
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
T PLL flow cytometry
Contributed by Min Shi, M.D., Ph.D. and Dragan Jevremovic, M.D., Ph.D.
FISH for TCL1A separation
Table 1
| FL with Castleman-like changes |
| FL with plasmacytic differentiation with or without IgG4 positive plasma cells |
| FL with marginal zone differentiation, typically involving MALT sites |
| FL negative for CD10, positive for MUM1 with BCL6 abnormalities |
| EBV positive FL |
| Floral variant of FL |
Contributed by Jennifer Chapman, M.D.
Castleman-like changes
Castleman-like changes
Floral variant
Floral variant
Follicular lymphoma negative for CD10 and expressing MUM1
Images hosted on other servers:
Gene mutations in JAK / STAT pathway
Contributed by Patricia Tsang, M.D., M.B.A.
Cold agglutinin disease (CAD)
CAD lymphoid aggregate
CAD (CD20)
CAD (CD3)
Table 1: T / NK cell entities - comparison of WHO (2016), WHO (2022) and ICC (2022)
| WHO HAEM4R | WHO HAEM5 | ICC |
| Precursor T cell neoplasms | ||
| T lymphoblastic leukemia / lymphoma | T lymphoblastic leukemia / lymphoma, NOS | T lymphoblastic leukemia / lymphoma |
Early T cell precursor lymphoblastic leukemia / lymphoma | Early T cell precursor lymphoblastic leukemia | Early T cell precursor acute lymphoblastic leukemia, NOS |
| Early T cell precursor acute lymphoblastic leukemia, BCL11B activated | ||
| NK lymphoblastic leukemia / lymphoma* | [Entity removed] | NK cell acute lymphoblastic leukemia* |
| Tumor-like lesions with T cell predominance | ||
| [Not included] | Kikuchi-Fujimoto disease | [Not included] |
| [Not included] | Indolent T lymphoblastic proliferation | [Not included] |
| [Not included] | Autoimmune lymphoproliferative syndrome | [Not included] |
| Mature T / NK cell leukemias | ||
| T prolymphocytic leukemia | T prolymphocytic leukemia | T cell prolymphocytic leukemia |
| T cell large granular lymphocytic leukemia | T large granular lymphocytic leukemia | T cell large granular lymphocytic leukemia |
| Chronic lymphoproliferative disorder of NK cells* | NK large granular lymphocytic leukemia | Chronic lymphoproliferative disorder of NK cells* |
| Adult T cell leukemia / lymphoma | Adult T cell leukemia / lymphoma | Adult T cell leukemia / lymphoma |
| Sézary syndrome | Sézary syndrome | Sézary syndrome |
| Aggressive NK cell leukemia | Aggressive NK cell leukemia | Aggressive NK cell leukemia |
| Primary cutaneous T cell lymphomas | ||
| Primary cutaneous CD4 positive small or medium T cell LPD* | Primary cutaneous CD4 positive small or medium T cell LPD | Primary cutaneous small or medium CD4 positive T cell LPD |
| Primary cutaneous acral CD8 positive T cell lymphoma* | Primary cutaneous acral CD8 positive lymphoproliferative disorder | Primary cutaneous acral CD8 positive lymphoproliferative disorder |
| Mycosis fungoides | Mycosis fungoides | Mycosis fungoides |
| Primary cutaneous CD30 positive T cell LPD: lymphomatoid papulosis | Primary cutaneous CD30 positive T cell LPD: lymphomatoid papulosis | Primary cutaneous CD30 positive T cell LPD: lymphomatoid papulosis |
| Primary cutaneous CD30 positive T cell LPD: primary cutaneous anaplastic large cell lymphoma | Primary cutaneous CD30 positive T cell LPD: primary cutaneous anaplastic large cell lymphoma | Primary cutaneous CD30 positive T cell LPD: primary cutaneous anaplastic large cell lymphoma |
| Subcutaneous panniculitis-like T cell lymphoma | Subcutaneous panniculitis-like T cell lymphoma | Subcutaneous panniculitis-like T cell lymphoma |
| Primary cutaneous gamma / delta T cell lymphoma | Primary cutaneous gamma / delta T cell lymphoma | Primary cutaneous gamma / delta T cell lymphoma |
| Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T cell lymphoma* | Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T cell lymphoma | Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T cell lymphoma |
| [Not included] | Primary cutaneous peripheral T cell lymphoma, NOS | [Not included] |
| Intestinal T cell and NK cell lymphoid proliferations and lymphomas | ||
| Indolent T cell lymphoproliferative disorder of the gastrointestinal tract* | Indolent T cell lymphoma of the gastrointestinal tract | Indolent clonal T cell LPD of the gastrointestinal tract |
| [Not included] | Indolent NK cell LPD of the gastrointestinal tract | Indolent NK cell LPD of the gastrointestinal tract |
| Enteropathy associated T cell lymphoma | Enteropathy associated T cell lymphoma | Enteropathy associated T cell lymphoma |
| Type II refractory celiac disease | ||
| Monomorphic epitheliotropic intestinal T cell lymphoma | Monomorphic epitheliotropic intestinal T cell lymphoma | Monomorphic epitheliotropic intestinal T cell lymphoma |
| Intestinal T cell lymphoma, NOS | Intestinal T cell lymphoma, NOS | Intestinal T cell lymphoma, NOS |
| Hepatosplenic T cell lymphoma | ||
| Hepatosplenic T cell lymphoma | Hepatosplenic T cell lymphoma | Hepatosplenic T cell lymphoma |
| Anaplastic large cell lymphoma | ||
| Anaplastic large cell lymphoma, ALK positive | ALK positive anaplastic large cell lymphoma | Anaplastic large cell lymphoma, ALK positive |
| Anaplastic large cell lymphoma, ALK negative | ALK negative anaplastic large cell lymphoma | Anaplastic large cell lymphoma, ALK negative |
| Breast implant associated anaplastic large cell lymphoma* | Breast implant associated anaplastic large cell lymphoma | Breast implant associated anaplastic large cell lymphoma |
| Nodal T follicular helper (TFH) cell lymphoma | ||
| Angioimmunoblastic T cell lymphoma | Nodal TFH cell lymphoma, angioimmunoblastic type | Follicular helper T cell lymphoma, angioimmunoblastic type |
| Follicular T cell lymphoma* | Nodal TFH cell lymphoma, follicular type | Follicular helper T cell lymphoma, follicular type |
| Nodal peripheral T cell lymphoma (PTCL) with TFH phenotype* | Nodal TFH cell lymphoma, NOS | Follicular helper T cell lymphoma, NOS |
| Other peripheral T cell lymphomas | ||
| Peripheral T cell lymphoma, NOS | Peripheral T cell lymphoma, NOS | Peripheral T cell lymphoma, NOS |
| EBV positive NK / T cell lymphomas | ||
| [Not included] [variant of PTCL, NOS] | EBV positive nodal T and NK cell lymphoma | Primary nodal Epstein-Barr virus positive T / NK cell lymphoma* |
| Extranodal NK / T cell lymphoma, nasal type | Extranodal NK / T cell lymphoma | Extranodal NK / T cell lymphoma, nasal type |
| EBV positive T and NK cell lymphoid proliferations and lymphomas of childhood | ||
| Severe mosquito bite allergy | Severe mosquito bite allergy | Severe mosquito bite allergy |
| Hydroa vacciniforme-like lymphoproliferative disorder | Hydroa vacciniforme lymphoproliferative disorder, classic or systemic | Hydroa vacciniforme lymphoproliferative disorder, classic or systemic |
| Chronic active EBV infection of T and NK cell type, systemic form | Systemic chronic active EBV disease | Chronic active EBV disease (T and NK cell phenotype) |
| Systemic EBV positive T cell lymphoma of childhood | Systemic EBV positive T cell lymphoma of childhood | Systemic EBV positive T cell lymphoma of childhood |
Contributed by Tom Deng, M.D.
Angiocentric destruction
Coagulative necrosis
CD3
CD56
EBER
Auerbach: 2022
Beck: 2021
Cerroni: 2020
Crane: 2021
Crane: 2024
Dorfman: 2023
Duffield: 2020
Foucar: 2019
Foucar: 2023
Gru: 2023
Hsi: 2017
Hudnall: 2019
IARC: 2017
Jaffe: 2016
King: 2023
Linden: 2015
Medeiros: 2021
Medeiros: 2023
Medeiros: 2017
Molina: 2019
Naeim: 2018
Subtil: 2019
Vasef: 2024
Wang: 2018
Wang: 2020
Find related Pathology books: hematopathology, dermatopathology, immunology / transplant, lab medicine, molecular, oncology
